Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

SHE:002082 Revenue

Wanbangde Pharmaceutical Holding Group had revenue of 214.60M CNY in the quarter ending June 30, 2026, a decrease of -18.54%. This brings the company's total for the last twelve months to 1.13B, down -11.15% year-over-year. In the year 2025, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.12B, down -22.59%. That makes Wanbangde Pharmaceutical Holding Group the 18,709th largest company in the world by revenue and 3,410th in China.

• Revenue (ttm): 1.13B
• Revenue Growth: -11.15%
• P/S Ratio: 5.97
• Revenue / Employee: 836.49K
• Employees: 1,348
• Market Cap: 6.73B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Divison 650.36M 58.2%
• Medical Instruments 466.97M 41.8%

By Geography

Chart

• China 785.48M 70.3%
• Overseas 331.85M 29.7%

Fiscal year ended Dec 31, 2025 See the full SHE:002082 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.12B	-326.04M	-22.59%
Dec 31, 2024	1.44B	-98.57M	-6.39%
Dec 31, 2023	1.54B	-244.49M	-13.69%
Jan 1, 2023	1.79B	-144.17M	-7.47%
Jan 1, 2022	1.93B	-11.77B	-85.91%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error